Allergies News and Research

Latest Allergies News and Research

Study links progression of lethal type of brain tumor with reduced expression of immune system genes

A new study links progression of a lethal type of brain tumor with reduced expression of more than 600 immune system genes, suggesting how complex the immune response is to the cancer and the resulting difficulty in targeting specific immune system proteins for treatment.

27 Apr 2010

ASPO meeting to focus on children's ear, nose and throat health

The American Society of Pediatric Otolaryngology will hold its annual meeting, April 30 - May 2, during the 2010 Combined Otolaryngology Spring Meetings - a joint meeting of eight otolaryngological societies in Las Vegas, NV.

27 Apr 2010

Patients can reduce frequency of Botox- Cosmetic injections and still receive same benefits: Research

Patients can decrease the frequency of Botox- Cosmetic injections after approximately two years and still receive most of the same wrinkle-smoothing cosmetic benefits, according to new research at Oregon Health & Science University.

27 Apr 2010

Nitration and allergy

Food proteins are nitrated through various processes. Just how these processes affect food allergies, however, is only now coming to light. The latest findings of a research project funded by the Austrian Science Fund FWF are being presented today at an international symposium in Italy. The findings show that in the case of a particular food protein the nitrated form can trigger a stronger allergic reaction than the non-nitrated form. At the same time, however, this nitrated form of the protein is better digested and therefore rendered "harmless".

27 Apr 2010

Nycomed, Merck enter co-promotion agreement for Daxas in Canada and Europe

Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with chronic obstructive pulmonary disease (COPD). In addition, the two companies have signed an exclusive distribution agreement for the commercialization of Daxas® in the United Kingdom.

26 Apr 2010

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

"A year after the emergence of swine flu [H1N1], U.S. health authorities and laboratories say the pandemic illustrated the need for new vaccine production techniques that are faster and more reliable," Agence France-Presse writes in an article that examines the challenges associated with current vaccine development practices and plans for future development.

24 Apr 2010

More tips to protect lungs on elevated-ozone days

It's a harmless-looking pale blue gas, a relative of the oxygen molecule that sustains life. In the upper atmosphere, a layer of it protects us from the sun's harmful rays.

23 Apr 2010

pHase Pharmaceuticals launches new drug development company

pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.

23 Apr 2010

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."

23 Apr 2010

Los Angeles slum housing health crisis

Over three hundred community members, stakeholders, and public health workers joined Los Angeles County Supervisor Mark Ridley-Thomas for a People's Hearing on Slum Housing and the unveiling of a position paper documenting the health crisis related to slum housing in Los Angeles.

22 Apr 2010

Swine flu vaccine blues

Exactly a year after the swine flu outbreak vigilance, newer vaccine techniques and other measures are being emphasized by researchers and key decision makers. Dr. Harvey Fineberg, chairman of the World Health Organization's pandemic review committee and President of the U.S. Institute of Medicine says, we need to look at the past to learn from it.

22 Apr 2010

CPAP medical device recommended for severe cases of sleep apnea

Sleep Apnea - While most people with mild sleep apnea are aware that they snore, they may not be aware of the health risks involved. There are plenty of jokes about the risk to marriage of snoring but the health risks to a person with chronic snoring vastly outweigh the relationship stress.

21 Apr 2010

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the first quarter of 2010, an increase of 4.0% as compared to the first quarter of 2009. Operational results declined 0.1% and the positive impact of currency was 4.1%.

21 Apr 2010

Prevalence of scalp fungus infection among children living in metropolitan areas

Approximately 7 percent of elementary school children across the bi-state, Kansas City metropolitan area are infected with the fungus Trichophyton tonsurans (T. tonsurans), the leading cause of ringworm in the U.S., according to a new study published today in Pediatrics. This is the largest study to date aimed at defining infection prevalence of the scalp fungus in children living in a metropolitan area and has implications for children nationwide.

20 Apr 2010

PRA International expands clinical research operations to New Zealand

PRA International, a leading Clinical Research Organization, announces it has established a legal entity and hired staff in New Zealand, which will complement the firm's extensive network of Asia-Pacific operations and partnerships.

19 Apr 2010

Protein Potential receives Phase II SBIR Grant to develop vaccine for prevention of P. vivax infections

Protein Potential LLC has received support from the National Institute of Allergy and Infectious Diseases of the NIH in the form of a Phase II Small Business Innovation Research Grant. The three-year award totaling approximately $3 million will support translational research to develop a vaccine for the prevention of malaria caused by the parasite Plasmodium vivax.

19 Apr 2010

7% of elementary school children infected with T. tonsurans: Pediatrics

Approximately 7 percent of elementary school children across the bi-state, Kansas City metropolitan area are infected with the fungus Trichophyton tonsurans, the leading cause of ringworm in the U.S., according to a new study published today in Pediatrics.

19 Apr 2010

MinuteClinic helps patients take control of allergies with treatment services seven days a week

As trees blossom and shed their pollen and grasses and weeds germinate in yards and fields across America, allergy sufferers are retreating indoors with seemingly no relief in sight. MinuteClinic, the walk-in medical clinic inside select CVS/pharmacy stores, can help patients breathe easier and take control of their allergies this spring with treatment services available seven days a week, including weekday evening hours.

16 Apr 2010

FAAN conference provides new insights about food allergies and anaphylaxis

The Food Allergy & Anaphylaxis Network (c) is bringing together parents, physicians, dietitians, caregivers, and others for its 17th Annual Food Allergy Conferences. The second of this year's four conferences will be held in Las Vegas and promises to give attendees new insights and strategies about food allergies and anaphylaxis.

16 Apr 2010

Low levels of vitamin D associated with lower lung function in children with asthma

Low levels of vitamin D are associated with lower lung function and greater medication use in children with asthma, according to researchers at National Jewish Health. In a paper published online this week in the Journal of Allergy & Clinical Immunology, Daniel Searing, MD, and his colleagues also reported that vitamin D enhances the activity of corticosteroids, the most effective controller medication for asthma.

16 Apr 2010

Allergies News and Research

Latest Allergies News and Research

Study links progression of lethal type of brain tumor with reduced expression of immune system genes

ASPO meeting to focus on children's ear, nose and throat health

Patients can reduce frequency of Botox- Cosmetic injections and still receive same benefits: Research

Nitration and allergy

Nycomed, Merck enter co-promotion agreement for Daxas in Canada and Europe

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

More tips to protect lungs on elevated-ozone days

pHase Pharmaceuticals launches new drug development company

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

Los Angeles slum housing health crisis

Swine flu vaccine blues

CPAP medical device recommended for severe cases of sleep apnea

Johnson & Johnson' first-quarter 2010 sales increase 4.0% to $15.6 billion

Prevalence of scalp fungus infection among children living in metropolitan areas

PRA International expands clinical research operations to New Zealand

Protein Potential receives Phase II SBIR Grant to develop vaccine for prevention of P. vivax infections

7% of elementary school children infected with T. tonsurans: Pediatrics

MinuteClinic helps patients take control of allergies with treatment services seven days a week

FAAN conference provides new insights about food allergies and anaphylaxis

Low levels of vitamin D associated with lower lung function in children with asthma

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Allergies News and Research

Latest Allergies News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in